Home
Christopher Rovaldi, COO: Keros Therapeutics KROS Planned sale · Filed 25/09/12
Trade details
- Type
- Planned sale notice
- Person
- Christopher RovaldiCOO
- Planned sale date
- 25/09/12
- Filed
- 25/09/12
0.2% of shares outstanding to be sold
Keros Therapeutics trades, last 26 weeks
What else happened in Keros Therapeutics around then
Filed or reported within 30 days of the trade day · 25/08/13~25/10/12Christopher Rovaldi's recent trades
No other trades yet.